A randomized, double-blind, placebo- and risperidone-controlled study on valnoctamide for acute mania

Volume: 19, Issue: 4, Pages: 285 - 294
Published: Jun 1, 2017
Abstract
Objectives Mood stabilizers administered for bipolar disorder during pregnancy, such as valproic acid, can increase the risk of congenital anomalies in offspring. Valnoctamide is a valproic acid derivative associated with a decreased risk for congenital abnormalities in animals. The present study evaluated the efficacy and safety of valnoctamide monotherapy, compared to placebo, in the treatment of patients in an acute manic episode. Methods A...
Paper Details
Title
A randomized, double-blind, placebo- and risperidone-controlled study on valnoctamide for acute mania
Published Date
Jun 1, 2017
Volume
19
Issue
4
Pages
285 - 294
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.